June 9, 2021
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor, Esq.
Re: | CannaPharmaRx, Inc. | |
Registration Statement on Form S-1 | ||
File No. 333-256123 |
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Mr. Gabor:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CannaPharmaRx, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement be declared effective at 9:00 AM, Eastern Time on June 11, 2021, or as soon as practicable thereafter.
This request for acceleration is subject, however, to your receiving a telephone call prior to such time from our legal counsel, Joshua D. Brinen of Brinen & Associates, LLC, confirming this request. Our legal counsel has full authority to withdraw or modify this acceleration request, orally or in writing.
Once the Registration Statement has been declared effective, the Company would appreciate if you could notify Nick Colvin at (778) 214-5075 and provide us with a written copy of the notice of effectiveness.
We request that we be notified of such effectiveness by a telephone call to Joshua D. Brinen of Brinen & Associates, LLC at (212) 330-8151.
We also respectfully request that a copy of the written order from the Commission verifying the effective time and date of such Registration Statement be sent to Brinen & Associates, LLC, attention: Joshua D. Brinen, via facsimile at 212-330-8151 or via electronic mail message at jbrinen@brinenlaw.com.
Sincerely,
CannaPharmaRx, Inc.
/s/ Nick Colvin
Chief Executive Officer
cc: John Cassels, Chief Financial Officer
NC:jdb